Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Metabolic Syndrome Diastolic Dysfunction
NCT02017561Phase 2Completed
- Sponsor
- University of Porto
- Start
- Jan 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in metabolic syndrome, diastolic dysfunction, sponsored by University of Porto. Started Jan 2014; status: completed.
02
Drugs
metformin
03
Conditions
metabolic syndromediastolic dysfunction
Beyond the preview
Go deeper on NCT02017561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017561.